Stephen Lin is a senior science officer at
California’s stem cell agency, CIRM. He
joined the Agency in 2015 to oversee the its $32M initiative to create a
repository of iPSCs from over 2400 individuals covering both genetically
complex and rare diseases, as well as a $40M genomics initiative that applies
cutting edge genomics and bioinformatics approaches to stem cell research and
therapeutic development. He is also
program lead on a $15M award to create a preclinical research organization
termed the Translating Center that focuses on preparing stem cell therapy
candidates for clinical trials through support with process development,
safety/toxicity studies, and manufacturing.
From 2012 he had been a staff scientist and team lead at Thermo Fisher
Scientific (formerly Life Technologies).
Prior to that he was a scientist since 2006 at StemCells, Inc of
California in the area of liver cell therapeutics. Dr. Lin received his Ph.D. from Washington
University in St. Louis under Jeffrey Gordon and did his postdoctoral research
at Harvard University under Stanley Korsmeyer.